These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18501995)

  • 1. Synthesis and activity of fibrillogenesis peptide inhibitors related to the 17-21 beta-amyloid sequence.
    Giordano C; Masi A; Pizzini A; Sansone A; Consalvi V; Chiaraluce R; Lucente G
    Eur J Med Chem; 2009 Jan; 44(1):179-89. PubMed ID: 18501995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of amyloid peptide fragment Aβ25-35 fibrillogenesis and toxicity by N-terminal β-amino acid-containing esapeptides: is taurine moiety essential for in vivo effects?
    Giordano C; Sansone A; Masi A; Masci A; Mosca L; Chiaraluce R; Pasquo A; Consalvi V
    Chem Biol Drug Des; 2012 Jan; 79(1):30-7. PubMed ID: 21995332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified-peptide inhibitors of amyloid beta-peptide polymerization.
    Findeis MA; Musso GM; Arico-Muendel CC; Benjamin HW; Hundal AM; Lee JJ; Chin J; Kelley M; Wakefield J; Hayward NJ; Molineaux SM
    Biochemistry; 1999 May; 38(21):6791-800. PubMed ID: 10346900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-based inhibitors of amyloid assembly.
    Sciarretta KL; Gordon DJ; Meredith SC
    Methods Enzymol; 2006; 413():273-312. PubMed ID: 17046402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategy for the generation of specific D-peptide amyloid inhibitors.
    Esteras-Chopo A; Pastor MT; Serrano L; López de la Paz M
    J Mol Biol; 2008 Apr; 377(5):1372-81. PubMed ID: 18328503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action.
    Bartolini M; Bertucci C; Bolognesi ML; Cavalli A; Melchiorre C; Andrisano V
    Chembiochem; 2007 Nov; 8(17):2152-61. PubMed ID: 17939148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation.
    Byun JH; Kim H; Kim Y; Mook-Jung I; Kim DJ; Lee WK; Yoo KH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5591-3. PubMed ID: 18793854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Abeta1-40 aggregation in vitro.
    Cellamare S; Stefanachi A; Stolfa DA; Basile T; Catto M; Campagna F; Sotelo E; Acquafredda P; Carotti A
    Bioorg Med Chem; 2008 May; 16(9):4810-22. PubMed ID: 18406152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and screening of a library of Re/Tc-based amyloid probes derived from beta-breaker peptides.
    Stephenson KA; Reid LC; Zubieta J; Babich JW; Kung MP; Kung HF; Valliant JF
    Bioconjug Chem; 2008 May; 19(5):1087-94. PubMed ID: 18407681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biophysical properties of a helical Abeta1-42 analog: Inhibition of fibrillogenesis and cytotoxicity.
    Matsuzaki K; Okada T; Tsukuda M; Ikeda K; Sohma Y; Chiyomori Y; Taniguchi A; Nakamura S; Ito N; Hayashi Y; Kiso Y
    Biochem Biophys Res Commun; 2008 Jul; 371(4):777-80. PubMed ID: 18471993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organofluorine inhibitors of amyloid fibrillogenesis.
    Török M; Abid M; Mhadgut SC; Török B
    Biochemistry; 2006 Apr; 45(16):5377-83. PubMed ID: 16618127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 'O-acyl isopeptide method' for the synthesis of difficult sequence-containing peptides: application to the synthesis of Alzheimer's disease-related amyloid beta peptide (Abeta) 1-42.
    Sohma Y; Hayashi Y; Kimura M; Chiyomori Y; Taniguchi A; Sasaki M; Kimura T; Kiso Y
    J Pept Sci; 2005 Jul; 11(8):441-51. PubMed ID: 15761877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide hairpin inhibitor of amyloid beta-protein oligomerization and fibrillogenesis.
    Yamin G; Ruchala P; Teplow DB
    Biochemistry; 2009 Dec; 48(48):11329-31. PubMed ID: 19877710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retro-enantio N-methylated peptides as beta-amyloid aggregation inhibitors.
    Grillo-Bosch D; Carulla N; Cruz M; Sánchez L; Pujol-Pina R; Madurga S; Rabanal F; Giralt E
    ChemMedChem; 2009 Sep; 4(9):1488-94. PubMed ID: 19591190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTIR spectroscopic studies on aggregation process of the beta-amyloid 11-28 fragment and its variants.
    Juszczyk P; Kołodziejczyk AS; Grzonka Z
    J Pept Sci; 2009 Jan; 15(1):23-9. PubMed ID: 19023881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and biological activity of beta-sheet breaker peptide conjugates.
    Rocha S; Cardoso I; Börner H; Pereira MC; Saraiva MJ; Coelho M
    Biochem Biophys Res Commun; 2009 Mar; 380(2):397-401. PubMed ID: 19250644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally designed dehydroalanine (DeltaAla)-containing peptides inhibit amyloid-beta (Abeta) peptide aggregation.
    Rangachari V; Davey ZS; Healy B; Moore BD; Sonoda LK; Cusack B; Maharvi GM; Fauq AH; Rosenberry TL
    Biopolymers; 2009 Jun; 91(6):456-65. PubMed ID: 19189374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
    Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
    J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.